Terzaghi L, Tessaro I, Raucci F, Merico V, Mazzini G, Garagna S, Zuccotti M, Franciosi F, Lodde V
a Reproductive and Developmental Biology Laboratory, Department of Health , Animal Science and Food Safety, University of Milan , Milan , Italy.
b Dipartimento di Biologia e Biotecnologie "Lazzaro Spallanzani," University of Pavia , Pavia , Italy.
Cell Cycle. 2016 Aug 2;15(15):2019-32. doi: 10.1080/15384101.2016.1192731. Epub 2016 Jun 3.
Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in both oocyte and ovarian somatic cells, where it is found in multiple cellular sub-compartments including the mitotic spindle apparatus. PGRMC1 localization in the maturing bovine oocytes mirrors its localization in mitotic cells, suggesting a possible common action in mitosis and meiosis. To test the hypothesis that altering PGRMC1 activity leads to similar defects in mitosis and meiosis, PGRMC1 function was perturbed in cultured bovine granulosa cells (bGC) and maturing oocytes and the effect on mitotic and meiotic progression assessed. RNA interference-mediated PGRMC1 silencing in bGC significantly reduced cell proliferation, with a concomitant increase in the percentage of cells arrested at G2/M phase, which is consistent with an arrested or prolonged M-phase. This observation was confirmed by time-lapse imaging that revealed defects in late karyokinesis. In agreement with a role during late mitotic events, a direct interaction between PGRMC1 and Aurora Kinase B (AURKB) was observed in the central spindle at of dividing cells. Similarly, treatment with the PGRMC1 inhibitor AG205 or PGRMC1 silencing in the oocyte impaired completion of meiosis I. Specifically the ability of the oocyte to extrude the first polar body was significantly impaired while meiotic figures aberration and chromatin scattering within the ooplasm increased. Finally, analysis of PGRMC1 and AURKB localization in AG205-treated oocytes confirmed an altered localization of both proteins when meiotic errors occur. The present findings demonstrate that PGRMC1 participates in late events of both mammalian mitosis and oocyte meiosis, consistent with PGRMC1's localization at the mid-zone and mid-body of the mitotic and meiotic spindle.
孕激素受体膜成分1(PGRMC1)在卵母细胞和卵巢体细胞中均有表达,在包括有丝分裂纺锤体装置在内的多个细胞亚区室中都能找到它。PGRMC1在成熟牛卵母细胞中的定位反映了其在有丝分裂细胞中的定位,这表明它在有丝分裂和减数分裂中可能有共同作用。为了验证改变PGRMC1活性会导致有丝分裂和减数分裂出现类似缺陷这一假说,研究人员在培养的牛颗粒细胞(bGC)和成熟卵母细胞中干扰了PGRMC1的功能,并评估了其对有丝分裂和减数分裂进程的影响。RNA干扰介导的bGC中PGRMC1沉默显著降低了细胞增殖,同时处于G2/M期的细胞百分比增加,这与M期停滞或延长一致。延时成像证实了这一观察结果,该成像揭示了后期核分裂的缺陷。与在有丝分裂后期事件中的作用一致,在分裂细胞的中央纺锤体中观察到PGRMC1与极光激酶B(AURKB)之间存在直接相互作用。同样,用PGRMC1抑制剂AG205处理或在卵母细胞中沉默PGRMC1会损害减数分裂I的完成。具体而言,卵母细胞排出第一极体的能力显著受损,而减数分裂图像畸变和卵质内染色质散射增加。最后,对AG205处理的卵母细胞中PGRMC1和AURKB定位的分析证实,当减数分裂出现错误时,这两种蛋白质的定位都会改变。目前的研究结果表明,PGRMC1参与了哺乳动物有丝分裂和卵母细胞减数分裂的后期事件,这与PGRMC1定位于有丝分裂和减数分裂纺锤体的中区和中间体一致。